Skip to Content

Eaton Vance Worldwide Health Sci A ETHSX

Analyst rating as of
  • NAV / 1-Day Return 12.62  /  1.12 %
  • Total Assets 1.0 Bil
  • Adj. Expense Ratio
  • Expense Ratio 1.210%
  • Distribution Fee Level Below Average
  • Share Class Type Front Load
  • Category Health
  • Investment Style Large Growth
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 0.21%
  • Turnover 27%

Morningstar’s Analysis ETHSX

Will ETHSX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Satisfactory rather than superior overall.

Senior Analyst



Eaton Vance Worldwide Health Sciences is an acceptable but not an exceptional source of exposure to its target sector, and all its share classes retain their Morningstar Analyst Ratings of Neutral.

Unlock our full analysis with Morningstar Investor